Stocktoria
Travere Therapeutics, Inc. TVTX
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2003-07-23
Travere Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 1,833,079 | $104.1M | 2.02% |
| TWO SIGMA INVESTMENTS, LP | 1,565,656 | $88.9M | 1.72% |
| D. E. Shaw & Co., Inc. | 1,440,469 | $81.8M | 1.58% |
| BlackRock Finance, Inc. | 7,644,789 | $62.8M | 8.41% |
| Point72 Asset Management, L.P. | 478,860 | $27.2M | 0.53% |
| AQR CAPITAL MANAGEMENT LLC | 270,048 | $15.3M | 0.3% |
| CITADEL ADVISORS LLC | 233,860 | $13.3M | 0.26% |
| MILLENNIUM MANAGEMENT LLC | 84,713 | $4.8M | 0.09% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.